FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a nanosuspension based on an alginate-chitosan polyelectrolyte complex with articaine hydrochloride for local anesthesia, containing the following ratio of components, wt.%: sodium alginate 0.015–0.018; calcium chloride 0.025–0.03; chitosan 0.008–0.01; articaine hydrochloride 0.95–1.0; and the rest is deionized water.
EFFECT: invention provides an increase in the local anesthetic effect, a decrease in toxicity and pain effect directly from the administration, and the safety of future use.
1 cl, 6 dwg, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION FOR WOUND TREATMENT AND PRODUCTS ON ITS BASIS | 2011 |
|
RU2467767C1 |
APPLICATION OF LOCAL ANESTHETIC FOR CORRECTION OF ALIMENTARY BEHAVIOUR OF PERSON AND METHOD OF APPLICATION | 2005 |
|
RU2352332C1 |
COMPOSITION FOR LOCAL ANESTHESIA | 2006 |
|
RU2308258C1 |
COMPOSITION FOR TOPICAL ANESTHESIA | 2006 |
|
RU2311897C2 |
PHARMACEUTICAL COMPOSITION ELICITING ANESTHETIC ACTIVITY | 2004 |
|
RU2261092C1 |
COMPOSITION FOR WOUND TREATMENT | 2008 |
|
RU2370270C1 |
MEDICINAL MATERIAL AND PRODUCTS BASED UPON THIS MATERIAL | 2002 |
|
RU2249467C2 |
AGENT FOR SURFACE ANESTHESIA | 2002 |
|
RU2225712C1 |
AGENT SHOWING ANESTHETIC AND ANTIBACTERIAL EFFECT | 1998 |
|
RU2153326C2 |
AGENT FOR TREATING DAMAGE TO EXTERNAL BODY TISSUES (VERSIONS) AND METHOD OF PRODUCING SAME | 2014 |
|
RU2578969C1 |
Authors
Dates
2023-10-31—Published
2023-04-25—Filed